therefore, three strains of Lactobacillus , each shown alone to have a protective effect against the development of EAE when administered before disease onset, were shown to inhibit established disease when administered as a therapeutic mixture
Watts RN
The company's antibody-drug conjugate and bispecific antibody pipeline includes peptide-linker components, and its oncology focus positions it strongly in the Oncology Peptide Therapy segment (11.79% CAGR through 2031)
PJ: Conceptualization, Funding acquisition, Writing review and editing
The company is also advancing: Ultra-long-acting amylin analog PF3945 Combination obesity therapies Multiple Nutrient-Stimulated Hormone (NuSH) programs My takeaway The obesity market has become highly competitive, but Pfizers strategy is differentiation rather than simply matching efficacy
Unlike older peptides like GHRP-6 or GHRP-2, Ipamorelin has minimal side effects and does not significantly affect cortisol, prolactin, or hunger